Alcohol beverage containing probiotics

Through microcapsule embedding technology, the problems of low survival rate of probiotics and high cold chain storage cost in alcoholic beverages are solved, and sufficient probiotic cell count is maintained when stored at room temperature, ensuring that the beverage provides health benefits in the long run and Maintain quality.

CN119095947APending Publication Date: 2024-12-06NATIONAL UNIVERSITY OF SINGAPORE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380030448.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-02-24
Filing Date
2023-02-24
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing alcoholic beverages containing probiotics have poor survival rates during storage and require cold chain transportation and storage, which are costly and difficult to monitor, resulting in the death of probiotic cells and cannot provide sufficient health benefits.

Method used

The microcapsule embedding probiotic technology allows alcoholic beverages to maintain sufficient probiotic cell count when stored at room temperature, including freeze-drying of probiotics and embedding them in a salt solution to form microcapsules and add them to fermented alcoholic beverages. middle.

Benefits of technology

Store at room temperature of 20-30°C for more than 7 days, or even 90 days, the cell count of microcapsule-embedded probiotics is maintained at ≥5.0Log CFU/mL to ensure that the beverage provides health benefits throughout the shelf life, such as improving the intestines. Health and immunity, and the color and taste of the beverage remain stable.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119095947A_ABST
    Figure CN119095947A_ABST
Patent Text Reader

Abstract

The invention relates to an alcoholic beverage containing probiotics. There is provided an alcoholic beverage comprising microencapsulated probiotics, characterized in that the microencapsulated probiotics have a cell count of > = 5.0 Log CFU / mL after storage of the beverage at a predetermined temperature for a predetermined time, where the predetermined temperature is 20-30 DEG C and the predetermined time is > = 7 days. A method of forming the probiotic-containing alcoholic beverage is also provided.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to an alcoholic beverage containing probiotics. Background Art

[0002] Alcoholic beverages containing probiotics are a non-dairy-based alternative delivery method for probiotics. However, such alcoholic beverages containing probiotics suffer from poor viability and low cell counts of probiotics, which become more prominent as the storage time after production increases. Therefore, beverages require cold chain transportation and storage to slow down the rate of probiotic cell death in alcoholic beverages. However, this approach is often expensive, difficult to monitor compliance, and insufficient to prevent probiotic cell death. Therefore, ordinary alcoholic beverages containing probiotics usually do not have enough probiotics to give consumers any health benefits.

[0003] There is therefore still a need for an improved alcoholic beverage containing probiotics. Summary of the invention

[0004] The present invention aims to solve these problems and / or to provide an improved alcoholic beverage containing probiotics.

[0005] In general, the present invention relates to an alcoholic beverage containing probiotics, which comprises microcapsules encapsulating probiotics. The alcoholic beverage containing probiotics of the present invention can be stored at room temperature while maintaining a sufficient amount of probiotics throughout the shelf life.

[0006] According to a first aspect, the present invention provides a probiotic-containing alcoholic beverage, comprising microcapsule-embedded probiotics, wherein after storing the beverage at a predetermined temperature for a predetermined time, the microcapsule-embedded probiotics have a cell count of ≥5.0LogCFU / mL, wherein the predetermined temperature is 20-30°C and the predetermined time is ≥7 days.

[0007] According to a particular aspect, the predetermined period may be ≥ 90 days.

[0008] According to a particular aspect, after storage of the beverage, the microencapsulated probiotics may have a cell count of ≥ 6.0 Log CFU / mL.

[0009] According to a specific aspect, the probiotic-containing alcoholic beverage may further comprise hops or a derivative thereof. The hops or a derivative thereof may be any suitable hops or a derivative thereof, and may have a suitable bitterness. Specifically, the hops or a derivative thereof may have a bitterness of ≤80 IBU.

[0010] The microcapsule-embedded probiotics contained in the probiotic-containing alcoholic beverage may be any suitable microcapsule-embedded probiotics. For example, the microcapsule-embedded probiotics may include microcapsule-embedded probiotic yeasts, microcapsule-embedded probiotic bacteria, or a combination thereof. Specifically, the microcapsule-embedded probiotic yeasts may include but are not limited to Saccharomyces yeasts, non-Saccharomyces yeasts, or a combination thereof. The microcapsule-embedded probiotic bacteria may include but are not limited to microcapsule-embedded spore-state probiotic bacteria. Specifically, the microcapsule-embedded probiotic bacteria may include Bacillus.

[0011] The microcapsule-embedded probiotics may have any suitable size. Specifically, the microcapsule-embedded probiotics may have an average diameter of 5-1000 μm.

[0012] After the storage, the alcoholic beverage containing probiotics may have a suitable pH. For example, after the storage, the pH of the alcoholic beverage containing probiotics may be 4-6.

[0013] After the storage, the alcoholic beverage containing probiotics may have a suitable Brix. For example, after the storage, the Brix of the alcoholic beverage containing probiotics may be 2-20° Bx.

[0014] According to a second aspect, the present invention provides a method for forming the above-mentioned probiotic-containing alcoholic beverage, the method comprising adding microcapsule-embedded probiotics to a fermented alcoholic beverage to form the probiotic-containing alcoholic beverage. The fermented alcoholic beverage may be any suitable fermented alcoholic beverage.

[0015] Prior to adding the microencapsulated probiotics to the fermented alcoholic beverage, the method may further include forming the microencapsulated probiotics. The forming may include adding the probiotics to a solution to form a probiotic solution, and prior to adding the probiotics to the solution, may further include freeze drying the probiotics. The forming may further include placing the probiotic solution in a salt solution to form the microencapsulated probiotics.

[0016] According to a particular aspect, the method may further comprise centrifuging and / or pasteurizing the fermented alcoholic beverage prior to adding the microencapsulated probiotics.

[0017] According to a particular aspect, after adding the microencapsulated probiotics, the method may further comprise carbonating the probiotic-containing alcoholic beverage.

[0018] The microcapsule-embedded probiotics added to the fermented alcoholic beverage may contain any suitable probiotics. For example, the probiotics contained in the microcapsule-embedded probiotics may be as described above. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] In order that the invention may be fully understood and readily put into practice, exemplary embodiments will now be described by way of non-limiting examples only, with reference to the illustrative drawings. In the drawings:

[0020] Figure 1 The experimental process is shown in the form of a process flow diagram;

[0021] Figure 2 The particle size distribution of beads formed by microencapsulated probiotics is shown;

[0022] Figure 3 The survival of (●) microencapsulated S. cerevisiae CNCM I-3856; (▼) microencapsulated S. boulardii CNCM I-745; (○) common S. cerevisiae CNCM I-3856; and (▽) common S. boulardii CNCM I-745 during storage at 30°C is shown; Figure 3 A shows survival in beer without hops; Figure 3 B shows survival in hopped beer;

[0023] Figure 4 The survival of (■) microencapsulated B. subtilis CU1 and (□) common B. subtilis CU1 are shown; Figure 4 A shows survival in beer without hops; Figure 4 B shows survival in hopped beer;

[0024] Figure 5 The survival rates of freeze-dried probiotics (black bars) and microencapsulated probiotics (white striped bars) are shown; Figure 5 A shows the survival rate in beer without hops; Figure 5 B shows the survival rate in hopped beer during storage at 30°C;

[0025] Figure 6 The change in Brix is ​​shown; Figure 6 A shows the changes in beer without hops; Figure 6B shows the changes in hopped beers during storage at 30°C: (●) microencapsulated Saccharomyces cerevisiae CNCM I-3856, (▼) microencapsulated Saccharomyces boulardii CNCM I-745, (○) common Saccharomyces cerevisiae CNCM I-3856 and (▽) common Saccharomyces boulardii CNCM I-745;

[0026] Figure 7 The change in Brix is ​​shown; Figure 7 A shows the changes in beer without hops; Figure 7 B shows the changes in hopped beer during storage at 30 °C: (■) microencapsulated Bacillus subtilis CU1 and (□) common Bacillus subtilis CU1;

[0027] Figure 8 The changes in pH are shown; Figure 8 A shows the changes in beer without hops; Figure 8 B shows the changes in hopped beers during storage at 30°C: (●) microencapsulated Saccharomyces cerevisiae CNCM I-3856, (▼) microencapsulated Saccharomyces boulardii CNCM I-745, (○) common Saccharomyces cerevisiae CNCM I-3856 and (▽) common Saccharomyces boulardii CNCM I-745;

[0028] Fig. 9 The changes in pH are shown; Fig. 9 A shows the changes in beer without hops; Fig. 9 B shows the changes in hopped beer during storage at 30°C: (■) microencapsulated Bacillus subtilis CU1 and (□) common Bacillus subtilis CU1; and

[0029] Fig.10 Sensory radar diagram showing average property values ​​calculated on a scale of 1 to 4 points: solid line - (●) microencapsulated Saccharomyces cerevisiae CNCM I-3856, (■) microencapsulated Saccharomyces boulardii CNCM I-745 and (▲) microencapsulated Bacillus subtilis CU1; dashed line - (○) non-microencapsulated Saccharomyces cerevisiae CNCM I-3856, (□) non-microencapsulated Saccharomyces boulardii CNCM I-745 and (△) non-microencapsulated Bacillus subtilis CU1; long dashed line - (◇) hopped beer without added probiotics. DETAILED DESCRIPTION

[0030] As explained above, there is a need for an improved probiotic-containing alcoholic beverage.

[0031] In summary, the present invention provides a probiotic-containing alcoholic beverage and a method for forming the same, which contains probiotics and is stable when stored at room temperature. Generally speaking, without proper refrigeration, it is difficult to expect the probiotics added to the beverage to survive, and the challenge is exacerbated for the probiotics added to the alcoholic beverage because the presence of antimicrobial compounds in the alcoholic beverage will hinder the growth of the probiotics and inhibit their survival. Compared with other probiotic-containing alcoholic beverages, the probiotic-containing alcoholic beverage of the present invention maintains a sufficient amount of probiotics throughout the shelf life at room temperature, thereby effectively giving consumers health benefits. For example, studies have shown that certain probiotic strains can improve intestinal health and digestion. Therefore, the probiotic-containing alcoholic beverage according to the present invention may bring health benefits such as improving intestinal health and enhancing immunity. The color and taste of the probiotic-containing alcoholic beverage are also maintained throughout the shelf life. The probiotic-containing alcoholic beverage may be stored at room temperature without cold chain and / or refrigeration, thereby facilitating transportation and storage.

[0032] According to a first aspect, the present invention provides a probiotic-containing alcoholic beverage, comprising microcapsule-embedded probiotics, wherein after storing the probiotic-containing alcoholic beverage at a predetermined temperature for a predetermined time, the microcapsule-embedded probiotics have a cell count of ≥5.0Log CFU / mL, wherein the predetermined temperature is 20-30°C and the predetermined time is ≥7 days.

[0033] For the purposes of the present invention, reference to an alcoholic beverage containing probiotics refers to an alcoholic beverage containing microencapsulated probiotics, and reference to a fermented alcoholic beverage refers to an alcoholic beverage before any addition of microencapsulated probiotics. Examples of alcohol include, but are not limited to, ethanol or ethyl alcohol. Specifically, the alcoholic beverage may have an alcohol content of ≥0.5% by volume.

[0034] The alcoholic beverage containing probiotics may have a suitable alcohol content. According to a specific aspect, the alcohol content of the alcoholic beverage containing probiotics may be ≥ 0.5% by volume. For example, the alcohol content may be 0.5-10%, 1.0-9.0%, 1.5-8.0%, 2.0-7.5%, 2.5-7.0%, 3.0-6.5%, 3.5-6.0%, 4.0-5.5%, 4.5-5.0%. Specifically, the alcohol content may be 4.0-8.0%.

[0035] The alcoholic beverage containing probiotics may include any suitable fermented alcoholic beverage. The fermented alcoholic beverage may be fermented by yeast, bacteria, mold, or any combination thereof. Examples of fermented alcoholic beverages may include, but are not limited to, beer, cider, fermented water, liquor, mead, tequila, rice wine, sparkling wine, spirits, wine, etc. According to a specific aspect, the fermented alcoholic beverage may be beer.

[0036] For the purposes of the present invention, microencapsulated probiotics are defined as probiotics encapsulated in capsules. The microencapsulated probiotics may have an average size of 5-1000 μm. Specifically, the microencapsulated probiotics may have an average size of 100-900 μm, 200-800 μm, 300-700 μm, 400-600 μm. Even more specifically, the microencapsulated probiotics may have an average size of 300-700 μm. For the purposes of the present invention, the average size is defined as the average diameter of ≥50% of the microencapsulated probiotics.

[0037] The microcapsule-embedded probiotics may have any suitable shape and size. For example, the microcapsule-embedded probiotics may be spherical.

[0038] The storage of the probiotic-containing alcoholic beverage may be performed at a predetermined temperature for a predetermined time to maintain the cell count of the microencapsulated probiotics at an appropriate level during the shelf life. For example, the predetermined temperature may be about 0-35° C. Specifically, the predetermined temperature may be about 5-30° C., 10-25° C., 15-20° C. Even more specifically, the predetermined temperature may be about 20-30° C.

[0039] The predetermined time may be ≥7 days. The predetermined time may be approximately ≥30 days, ≥60 days, ≥90 days, ≥120 days. Even more specifically, the predetermined time may be ≥90 days. The alcoholic beverage advantageously maintains the cell count of the microencapsulated probiotics at an effective level to impart health benefits throughout the shelf life.

[0040] Prior to the storage, the probiotic-containing alcoholic beverage may contain a suitable initial amount of microencapsulated probiotics. For example, prior to the storage, the initial cell count of the microencapsulated probiotics may be ≥6.0 Log CFU / mL. Specifically, prior to the storage, the initial cell count of the microencapsulated probiotics may be ≥6.0-8.0 Log CFU / mL.

[0041] After the storage, the probiotic-containing alcoholic beverage may contain a suitable amount of microcapsule-embedded probiotics, which has an effective amount to give health benefits. For example, the probiotic bacteria may have a cell count of ≥5.0Log CFU / mL. Specifically, the probiotic bacteria contained in the probiotic-containing alcoholic beverage may have a cell count of 5.0-11.0LogCFU / mL, 5.5-10.5Log CFU / mL, 6.0-10.0Log CFU / mL, 6.5-9.5Log CFU / mL, 7.0-9.0LogCFU / mL, 7.5-8.5Log CFU / mL. Even more specifically, after the storage, the microcapsule-embedded probiotics contained in the probiotic-containing alcoholic beverage may have a cell count of ≥6.0CFU / mL.

[0042] The probiotic-containing alcoholic beverage may contain hops. For the purposes of the present invention, reference to hops refers to hops and / or its derivatives. The hops may be any suitable hops. For example, the hops may be an isomerized hop extract.

[0043] The hops may have a suitable bitterness. For example, the hops may have a bitterness of ≤80 IBU. Specifically, the bitterness may be 0-80 IBU, 5-75 IBU, 10-70 IBU, 15-65 IBU, 20-60 IBU, 25-55 IBU, 30-50 IBU, 35-45 IBU. Even more specifically, the hops may have a bitterness of 5-30 IBU. IBU refers to international bitterness units and is a unit of measure for the concentration of hop compounds in the alcoholic beverage. Specifically, the IBU measures the parts per million (ppm) of isohumulones in the probiotic-containing alcoholic beverage.

[0044] The microencapsulated probiotics contained in the probiotic-containing alcoholic beverage may be any suitable microencapsulated probiotic yeast and / or microencapsulated probiotic bacteria. The microencapsulated probiotic yeast and / or microencapsulated probiotic bacteria may contain any suitable live microorganisms that, when provided in sufficient amounts, confer health benefits on the host.

[0045] For example, the microcapsule-embedded probiotic yeast may include but is not limited to yeast and / or non-saccharomyces yeast, such as Pichia, Kluyveromyces, Hanseniaspora, Candida and Zygosaccharomyces. Specifically, the microcapsule-embedded probiotic yeast may include but is not limited to Saccharomyces boulardii, Saccharomyces cerevisiae, or a combination thereof.

[0046] The microcapsule-embedded probiotic bacteria may include microcapsule-embedded spore-state probiotic bacteria. For the purpose of the present invention, spore-state probiotic bacteria are defined as spore-state bacteria, which become metabolically inert and resistant to external stress when in the spore state, and can also give health benefits to the host when provided in sufficient amounts, and are microencapsulated as described above. The microcapsule-embedded spore-state probiotic bacteria may include Bacillus. Specifically, the microcapsule-embedded spore-state probiotic bacteria may include Bacillus subtilis, Bacillus coagulans, Bacillus cereus, Bacillus clausii, Bacillus licheniformis, Bacillus polyfermenticus, Bacillus pumilus, or a combination thereof. Even more specifically, the microcapsule-encapsulated probiotic bacteria in spore state may include Bacillus subtilis.

[0047] The alcoholic beverage containing probiotics may have a suitable pH. For example, the pH of the alcoholic beverage containing probiotics may be ≥ 3.8. Specifically, the pH may be 4.0-6.0.

[0048] The alcoholic beverage containing probiotics may have a suitable Brix or its specific gravity equivalent. Brix is ​​a unit of measurement for the amount of sugar in the alcoholic beverage. For example, 1°Bx means that 100g of the alcoholic beverage contains 1g of sucrose. Therefore, the higher the Brix in the alcoholic beverage, the higher the sugar content may be. For example, the Brix of the alcoholic beverage containing probiotics may be 2-20°Bx. Specifically, the Brix may be 3-19°Bx, 4-18°Bx, 5-17°Bx, 6-16°Bx, 7-15°Bx, 8-14°Bx, 9-13°Bx, 10-12°Bx. Even more specifically, the Brix of the alcoholic beverage containing probiotics may be 5-15°Bx.

[0049] According to a second aspect of the present invention, there is provided a method for forming a probiotic-containing alcoholic beverage of the first aspect, the method comprising adding microcapsule-encapsulated probiotics to a fermented alcoholic beverage to form the probiotic-containing alcoholic beverage. For the purposes of the present invention, a fermented alcoholic beverage is defined as any beverage containing alcohol, which may be fermented by yeast, bacteria, molds or any combination thereof. The fermented alcoholic beverage may be any suitable fermented alcoholic beverage. Examples of fermented alcoholic beverages may include, but are not limited to, beer, cider, fermented water, liquor, mead, tequila, rice wine, sparkling wine, spirits, wine, and the like. According to a specific aspect, the fermented alcoholic beverage may be beer. The probiotic-containing alcoholic beverage formed by the fermented alcoholic beverage thus contains microcapsule-encapsulated probiotics.

[0050] According to a specific aspect, before adding the microcapsule-embedded probiotics to the fermented alcoholic beverage, the method for forming the probiotic-containing alcoholic beverage may further include forming the microcapsule-embedded probiotics. Forming the microcapsule-embedded probiotics may include adding the probiotics to a solution to form a probiotic solution. The solution may be any solution suitable for forming a coating to encapsulate the probiotics, thereby encapsulating the probiotics in microcapsules. For example, the solution may be a gelatin solution, an alginate solution, a chitosan solution, a carrageenan solution, a glyceride solution, or a combination thereof. Specifically, the solution may be sodium alginate, calcium alginate, or a combination thereof. The solution may be processed to food grade so that the intake of the microcapsule-embedded probiotics does not cause health hazards. For example, the solution can be sterilized.

[0051] Before adding the probiotics to the solution, forming the microcapsules to encapsulate the probiotics may further include freeze-drying the probiotics. The freeze-drying is beneficial for extending the shelf life and improving the activity of the probiotics.

[0052] Forming the microcapsules encapsulating probiotics may further include placing the probiotic solution in a salt solution to form the microcapsules encapsulating probiotics. The salt solution may be any salt solution suitable for solidifying the probiotic solution to allow the probiotics to be encapsulated in a coating formed by the solution. For example, the salt solution may be calcium chloride.

[0053] Before adding the microcapsule-embedded probiotics, the method for forming the probiotic-containing alcoholic beverage may further include centrifuging and / or pasteurizing the fermented alcoholic beverage. The centrifugation may be performed at any suitable speed, any suitable temperature, and any suitable time. For example, the centrifugation may be performed at 500-10000rpm, 1000-9000rpm, 2000-8000rpm, 3000-7000rpm, 4000-6000rpm. Specifically, the centrifugation may be performed at 1000-3000rpm. The centrifugation may be performed at a temperature of 4-10°C, 5-9°C, or 6-8°C. Specifically, the centrifugation may be performed at a temperature of 4°C. The centrifugation may be performed for 5-30 minutes, 10-25 minutes, or 15-20 minutes. Specifically, the centrifugation may be performed for 10-20 minutes. The pasteurization may be performed at any suitable temperature and for any suitable time. For example, the pasteurization may be performed at a temperature of 50-90° C., 55-85° C., or 60-80° C. Specifically, the pasteurization may be performed at a temperature of 55-85° C. The pasteurization may be performed for 5-1800 s.

[0054] After adding the microcapsule-embedded probiotics, the method of forming the probiotic-containing alcoholic beverage may further include carbonating the probiotic-containing alcoholic beverage. The carbonation may include dissolving carbon dioxide into the probiotic-containing alcoholic beverage, thereby generating foam and changing the mouthfeel of the probiotic-containing alcoholic beverage. The carbonation may give the probiotic-containing alcoholic beverage a pleasant and refreshing taste to consumers.

[0055] The microencapsulated probiotics added to the fermented alcoholic beverage may be any suitable microencapsulated probiotics. For example, the microencapsulated probiotics may be as described above. Adding the microencapsulated probiotics may include adding a suitable amount of microencapsulated probiotics to the fermented alcoholic beverage. For example, the microencapsulated probiotics added in the amount may have a cell count of 6.0-8.0 Log CFU / mL.

[0056] Now that the present invention has been summarized, the present invention will be more readily understood by reference to the following examples. The following examples are provided by way of illustration and are not intended to limit the present invention.

[0057] Example

[0058] Materials and methods

[0059] The experimental process is as follows Figure 1 As shown in the process flow diagram.

[0060] The wort without hops and the wort with hops were prepared separately and inoculated with brewer's yeast (wheat beer yeast Saccharomyces cerevisiae SafAle WB-06). The fermentation container was covered with an airlock and stored at 10-30°C for 5-30 days of fermentation. The fermented beer obtained was centrifuged and pasteurized at 55-85°C for 5 seconds to 30 minutes.

[0061] Freeze-dried probiotic yeast (Saccharomyces cerevisiae CNCM I-3856 and Saccharomyces boulardii CNCM I-745) and spore-state bacteria (Bacillus subtilis CU1 spore state) were mixed with food-grade sterilized calcium alginate solution (0.2%-2% w / v, PhoonHuat Pte Ltd, Malaysia) to form a probiotic solution. The probiotic solution was filtered through a 70 μm sterilized simple filter (Greiner Bio-One, Germany).

[0062] The probiotics were microencapsulated in a laminar flow cabinet using a microfluidic droplet generation system obtained from the Singapore Institute of Manufacturing Technology (SIMtech). The probiotic solution was injected into sterile CaCl2 by a microfluidic disposable chip respectively. According to preliminary tests, the droplet size of the probiotic solution can be adjusted by using a computer to set parameters. The microencapsulated beads of Saccharomyces cerevisiae CNCM I-3856, Saccharomyces boulardii CNCM I-745 and Bacillus subtilis CU1 spores were separated from the CaCl2 solution with filter paper and subsequently washed three times with deionized water.

[0063] The microcapsule-embedded probiotics were inoculated into 330 mL of beer without hops and beer with hops, respectively. Saccharomyces cerevisiae CNCM I-3856, Saccharomyces boulardii CNCM I-745 and Bacillus subtilis CU1 (spore state) in each of the inoculated beers had a cell count of at least 6.0 Log CFU / mL. The same amount of non-microcapsule-embedded freeze-dried probiotics was also inoculated into beer without hops and beer with hops as a control group.

[0064] The beer samples were immediately dispensed into 15 mL centrifuge tubes (12 mL per tube) without carbonation and stored at 30°C for more than 3 months to study the stability and survival of the probiotics. Three samples were taken for each treatment to monitor the probiotic cell count and physicochemical parameters.

[0065] morphology

[0066] The particle size of the microcapsules was measured by laser diffraction / scattering particle size distribution analyzer LA-950 (Horiba, France).

[0067] Probiotic cell count

[0068] Probiotic yeast cell counts were monitored for 2 days at 30° C. on potato dextrose agar (PDA) (Oxoid, Basingstoke, Hampshire, UK) using the diffusion plate method. Bacillus subtilis CU1 cell counts were monitored for 24 hours at 37° C. on Mueller-Hinton agar (Oxoid, Basingstoke, Hampshire, UK) using the pour plate method. The microencapsulated probiotic yeast and Bacillus subtilis CU1 were lysed with 1% w / v sodium citrate and the cell counts of the probiotic yeast and Bacillus subtilis CU1 were monitored as above.

[0069] Brix and pH

[0070] The pH and Brix of the samples were measured using a pH meter (Metrohm, Switzerland) and a refractometer (ATAGO, Tokyo, Japan), respectively.

[0071] Sensory evaluation

[0072] The experiment was repeated and the beer samples were divided into glass bottles (330 mL each) for sensory evaluation. After storage at 30°C for 3 months, 8 trained panelists evaluated the probiotic beer samples using a 4-point scale quantitative descriptive analysis based on 5 attributes: appearance, sweetness, aftertaste, body and mouthfeel scores (Table 1).

[0073] Table 1: Quantitative descriptive analysis of the four-point scale of beer attributes

[0074] property 1 2 3 4 Appearance Too light Refreshing Tempting Too dark Sweetness Not at all Slightly Moderate Too sweet Aftertaste light concentrated continued strong Body thin Medium slightly thin Medium to full Extremely full Taste score Difference Not satisfactory Satisfactory good

[0075] Results and discussion

[0076] morphology

[0077] The probiotic microencapsulated beads were spherical and of similar size. More than 70% of the beads had a diameter between 300 μm and 700 μm, and the median size was 338 μm. The other 20% of the beads had a diameter ranging from 5 μm to 20 μm ( Figure 2 ). The particle morphology of most microencapsulated probiotics did not change significantly during storage, indicating that the microencapsulated beads would not dissolve easily in beer.

[0078] Probiotic cell count

[0079] The survival of the microencapsulated probiotics in the beer samples without hops and with hops during storage at 30°C for up to 120 days is as follows: Figure 3 and Figure 4As shown. In beer without hops, the cell count of the microencapsulated Saccharomyces cerevisiae CNCM I-3856 decreased from 7.70 Log CFU / mL to 6.28 Log CFU / mL within the first month of storage, and then remained stable at about 6.3 Log CFU / mL for the next 3 months. The microencapsulated Saccharomyces boulardii CNCM I-745 was more stable and maintained a cell count of greater than 6.3 Log CFU / mL in beer without hops stored at 30°C for about 4 months ( Figure 3 A). Compared with the microencapsulated probiotic yeast, the cell count of the non-microencapsulated probiotic yeast rapidly decreased by about 1 Log CFU / mL from the second month of storage, and a cell count of less than 5.7 Log CFU / mL was retained in beer without hops. This indicates that microencapsulation helps the survival of probiotics in beer without hops during storage at 30°C, especially from the middle of storage.

[0080] The cell counts of the probiotic yeasts in the beer with hops and without microencapsulation were kept above 6.3 Log CFU / mL, among which the microencapsulated Saccharomyces boulardii CNCM I-745 was the most stable in the beer with hops ( Figure 3 B) However, microencapsulation had limited effect on the survival of S. cerevisiae CNCM I-3856 in hopped beer.

[0081] Similarly, microencapsulation had a greater effect on the stability of Bacillus subtilis CU1 (spore state) in beer without hops than in beer with hops ( Figure 4 In beer without hops, after storage at 30°C for nearly 4 months, the cell count of the non-microencapsulated Bacillus subtilis CU1 continued to decrease from 7.3 Log CFU / mL to 4.5 Log CFU / mL, during which time the cell count of the microencapsulated Bacillus subtilis CU1 decreased by only about 0.9 Log CFU / mL, from 6.9 Log CFU / mL to 6.0 Log CFU / mL ( Figure 4 A). One possible reason is that the non-microencapsulated B. subtilis germinated in hop-free beer without iso-alpha acids, which made the bacteria more susceptible to environmental stress without a protein coat. The microencapsulation process provided a calcium alginate coating to the B. subtilis.

[0082] In the beer with hops, the microencapsulated Bacillus subtilis cell counts were stable from mid-storage, while the non-microencapsulated cultures decreased slightly over the same period. In the beer with hops, the Bacillus subtilis cell counts in the microencapsulated and control groups remained at 6.7 Log CFU / mL and 6.3 Log CFU / mL, respectively ( Figure 4 B).

[0083] Effect of microencapsulation on the survival rate of probiotics in beer samples Figure 5 After microencapsulation, the survival rates of Saccharomyces cerevisiae CNCM I-3856, Saccharomyces boulardii CNCM I-745 and Bacillus subtilis CU1 in beer without hops increased significantly from about 3% to 5%, from 4% to 17% and from 0.1% to 17%, respectively ( Figure 5 A). This indicates that microencapsulation can promote the viability of probiotics in beer without hops. After microencapsulation, the survival rates of Saccharomyces boulardii CNCM I-745 and Bacillus subtilis CU1 in beer with hops increased by at least 5 times, reaching approximately 45% and 65%, respectively, after storage at 30°C for 4 months ( Figure 5 B) However, the contribution of microencapsulation to the survival of S. cerevisiae CNCM 1-3856 in hopped beer was not significant.

[0084] Brix and pH

[0085] After adding the microencapsulated probiotics, the Brix of both the hopless and hopped beers remained stable, indicating that the microencapsulation protected the probiotic strains from environmental stress during storage at 30°C ( Figure 6 and Figure 7 The addition of non-microencapsulated probiotic yeast and spore-forming bacteria resulted in slight fluctuations in the Brix values ​​of hopless and hopped beers during storage.

[0086] Microencapsulation has limited effect on the pH of yeast-based probiotic beer ( Figure 8). Both non-microencapsulated and microencapsulated probiotic yeasts did not affect the pH of beer without hops and beer with hops, except for Saccharomyces cerevisiae CNCM I-3856 in beer with hops. Both non-microencapsulated and microencapsulated Saccharomyces cerevisiae CNCM I-3856 increased the pH of hopped beer by approximately 0.3 units (from 4.5 to 4.8) at the end of storage, which may be related to the acid metabolism produced by the yeast released during storage. For beer containing spore-state probiotic bacteria, the pH of hopped beer with the addition of microencapsulated Bacillus subtilis CU1 was more stable than the pH of beer with the addition of non-microencapsulated freeze-dried Bacillus subtilis CU1 ( Fig. 9 ).

[0087] Sensory evaluation

[0088] Sensory evaluation of probiotic beers containing non-microencapsulated probiotics and microencapsulated probiotics Fig.10 As shown. After 3 months of storage, the appearance of the beer containing non-microencapsulated probiotics became "too dark", while the appearance of both non-probiotic beer and beer containing microencapsulated probiotics remained "fresh". This shows that microencapsulation of probiotics effectively prevents beer from turning brown during storage. Microencapsulation may also reduce the bitterness of the beer aftertaste. The addition of Bacillus subtilis CU1 (in non-microencapsulated and microencapsulated forms) slightly increased the sweetness of the beer and reduced the body of the beer. The addition of microencapsulated Saccharomyces cerevisiae CNCM I-3856 also reduced the body of the beer.

[0089] According to the taste score, the non-probiotic beer after storage was "satisfactory", which was the same as the beer with the addition of non-microencapsulated Bacillus subtilis. After storage, the addition of non-microencapsulated probiotic yeast reduced the taste score to "unsatisfactory". Microencapsulation improved the taste score of the beer, with the beer containing microencapsulated Bacillus subtilis having the highest taste score, such as Fig.10 These results indicate that the addition of microencapsulated probiotics can maintain and even improve the sensory qualities of probiotic beer during storage at 30 °C.

[0090] Therefore, the results show that microencapsulation effectively increases the stability of probiotics in beer. All microencapsulated probiotics maintained a cell count of greater than 6LogCFU / mL in both hopped and hopless beer during storage at 30°C for 4 months. In addition, the addition of microencapsulated probiotics has a beneficial effect on the sensory properties of probiotic beer and effectively prevents the beer from turning brown during storage. Compared with probiotic yeast, the stability of Bacillus subtilis in beer is more significantly improved after microencapsulation. Similarly, the taste score of beer with microencapsulated Bacillus subtilis was the highest among all beer samples.

[0091] While the foregoing description has described exemplary embodiments, those skilled in the art will appreciate that many variations are possible without departing from the invention.

Claims

1. An alcoholic beverage containing probiotics, comprising microcapsule-embedded probiotics, characterized in that: After storing the probiotic-containing alcoholic beverage at a predetermined temperature for a predetermined time, the microencapsulated probiotics have a cell count of ≥5.0 Log CFU / mL, wherein the predetermined temperature is 20-30° C., and the predetermined time is ≥7 days.

2. The probiotic-containing alcoholic beverage according to claim 1, characterized in that The predetermined time is ≥90 days.

3. The probiotic-containing alcoholic beverage according to claim 1 or 2, characterized in that: After storing the probiotic-containing alcoholic beverage, the microencapsulated probiotics have a cell count of ≥6.0 Log CFU / mL.

4. The probiotic-containing alcoholic beverage according to any one of the preceding claims, characterized in that The probiotic-containing alcoholic beverage comprises hops or a derivative thereof.

5. The alcoholic beverage containing probiotics according to claim 4, characterized in that The hops or derivatives thereof have a bitterness of ≤80 IBU.

6. The probiotic-containing alcoholic beverage according to any one of the preceding claims, characterized in that The microcapsule-embedded probiotics include microcapsule-embedded probiotic yeasts, microcapsule-embedded probiotic bacteria, or a combination thereof.

7. The probiotic-containing alcoholic beverage according to claim 6, characterized in that: The microcapsule-embedded probiotic yeast includes yeast of the genus Saccharomyces, yeast of the genus non-Saccharomyces, or a combination thereof.

8. The probiotic-containing alcoholic beverage according to claim 6 or 7, characterized in that: The microcapsule-embedded probiotic yeast includes Saccharomyces cerevisiae, Saccharomyces boulardii, or a combination thereof.

9. The probiotic-containing alcoholic beverage according to claim 6, characterized in that: The microcapsule-embedded probiotic bacteria include microcapsule-embedded probiotic bacteria in spore state.

10. The alcoholic beverage containing probiotics according to claim 9, characterized in that The microcapsule-embedded probiotic bacteria in spore state include Bacillus.

11. The probiotic-containing alcoholic beverage according to any one of the preceding claims, characterized in that The microcapsule-embedded probiotics have an average size of 5-1000 μm.

12. The probiotic-containing alcoholic beverage according to any one of the preceding claims, characterized in that After storage of the probiotic-containing alcoholic beverage, the beverage had a pH of 4-6.

13. The probiotic-containing alcoholic beverage according to any one of the preceding claims, characterized in that After storing the probiotic-containing alcoholic beverage, the probiotic-containing alcoholic beverage has a Brix of 2-20° Bx.

14. A method of forming a probiotic-containing alcoholic beverage according to any one of the preceding claims, the method comprising adding microencapsulated probiotics to a fermented alcoholic beverage to form the probiotic-containing alcoholic beverage.

15. The method of claim 14, further comprising forming the microencapsulated probiotics before adding the microencapsulated probiotics to the fermented alcoholic beverage, wherein the forming comprises adding the probiotics to a solution to form a probiotic solution.

16. The method according to claim 15, characterized in that Before adding the probiotics to the solution, forming the microcapsules to encapsulate the probiotics further comprises freeze-drying the probiotics.

17. The method according to claim 16, characterized in that The forming of the microcapsule-embedded probiotics further comprises placing the probiotic solution in a salt solution to form the microcapsule-embedded probiotics.

18. The method according to any one of claims 14 to 17, further comprising centrifuging and / or pasteurizing the fermented alcoholic beverage before adding the microencapsulated probiotics.

19. The method according to any one of claims 14 to 18, further comprising carbonating the probiotic-containing alcoholic beverage after adding the microencapsulated probiotics.

20. The method according to any one of claims 14 to 19, characterized in that: The microcapsule-embedded probiotics include microcapsule-embedded probiotic yeasts, microcapsule-embedded probiotic bacteria, or a combination thereof.

21. The method according to claim 20, characterized in that The microcapsule-embedded probiotic yeast includes yeast of the genus Saccharomyces, yeast of the genus non-Saccharomyces, or a combination thereof.

22. The method according to claim 20 or 21, characterized in that The microcapsule-embedded probiotic yeast includes Saccharomyces cerevisiae, Saccharomyces boulardii, or a combination thereof.

23. The method according to claim 20, characterized in that The microcapsule-embedded probiotic bacteria include microcapsule-embedded probiotic bacteria in spore state.

24. The method according to claim 23, characterized in that The microcapsule-embedded probiotic bacteria in spore state include Bacillus.